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ScienceDirectAdaptation to metabolic needs and changing environments is a
basic requirement of every living system. These adaptations
can be very quick and mild or slower but more drastic. In any
case, cells have to constantly monitor their metabolic state and
requirements.In this article we review general concepts as well
as recent advances on how metabolites can regulate
metabolic fluxes. We discuss how cells sense metabolite
levels and how changing metabolite levels regulate metabolic
enzymes on different levels, from specific allosteric regulation
to global transcriptional regulation. We thereby focus on local
metabolite sensing in mammalian cells and show that several
major discoveries have only very recently been made.
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Introduction
In recent years, interest in cellular metabolism as a
possible intervention point to treat diseases has been
renewed, which has led to the discovery of new links
between metabolism and the pathogenesis of various
diseases [1]. However, identifying regulatory nodes
within the metabolic network is challenging due to its
complex structure. Since most of the anabolic and cata-
bolic pathways share a common set of metabolites, com-
plex regulatory mechanisms have evolved to ensure that
metabolites are moved through the correct pathways at
the correct rate to match the cell’s ever-changing meta-
bolic requirements.
Regulation of cellular metabolism may occur at several
different levels (Figure 1), beginning at the gene
encoding different enzyme isoforms, followed by theCurrent Opinion in Biotechnology 2015, 34:16–22 transcriptional level that selects which genes are acti-
vated. Subsequently, alternative splicing, mRNA
stability, translation, and protein degradation control
enzyme abundances. Since all of these mechanisms are
long-term regulations (hours to days), they are classified
as ‘coarse’ regulations [2]. Usually, coarse regulations are a
response to long-term environmental changes or hormo-
nal stimulation and require newly synthesized proteins.
More rapid adjustments (seconds to minutes) of cellular
metabolism, however, change the activity of enzymes
already present in the cell. Usually, they are triggered
by changes in local concentrations of metabolites leading
to an allosteric or post-translational regulation of enzyme
activity. These mechanisms are classified as ‘fine’ regu-
lations and provide short-term regulation of pathways that
need to be constitutively active [2].
In this article we critically review how metabolite levels
control the regulatory mechanisms depicted in
Figure 1. To this end, we first need to define what we
consider as a regulatory role of a metabolite. We consider
a metabolite to have a role in regulating cellular metab-
olism if it fulfills the following two conditions: first, the
concentration of the metabolite must be able to fluctuate
in response to internal or external perturbations; second,
and more importantly, this concentration change must
trigger a response which leads to a change in activity of
one or more specific enzymes. In the following we will
review general mechanisms that fulfill these two con-
ditions, accompanied by specific examples of metabolites
recently shown to regulate mammalian cellular metab-
olism.
Although we here only review local sensing mechanisms,
it should be noted that in complex organisms metabolite
sensing occurs in dedicated cell types which initiate
specific systemic hormonal signaling which is then inte-
grated in a cell-type specific manner [3].
Substrate and product concentrations
All metabolic reactions are dependent both on the con-
centration of the substrate and product. Most metabolic
reactions are catalyzed by enzymes. Enzymes bind their
substrate with a characteristic affinity and a parameter
KM. The KM value describes the concentration of the
substrate for a given enzyme concentration at which the
reaction is at half maximum speed and is of fundamental
importance for the following reason: in case the sub-
strate’s concentration is much higher than the KM value,www.sciencedirect.com
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Enzyme activity, and thus metabolic fluxes can be modulated by varying the number of enzyme molecules within the cell (blue background), the
enzyme’s subcellular location (purple background) or by changing the activity of the enzyme molecules already present in a cell (yellow
background).the enzyme is mostly saturated and changes in substrate
concentration will not significantly influence its activity.
Within a cell, concentrations of most substrates of central
carbon metabolism are below or close to KM, except for
those enzymes that catalyze initial steps of amino and
nucleic acid degradation [2,4]. Therefore, small changes
in substrate concentrations in vivo can in fact induce
significant changes in metabolic fluxes. Enzymes follow-
ing Michaelis–Menten kinetics show a hyperbolic satur-
ation kinetic, meaning that with increasing substrate
concentration the reaction speed asymptotically con-
verges to the maximal speed and, thus, the flux change
per concentration change converges to zero. That being
said, a significant flux increase through an enzymatic
reaction where the substrate concentration is higher than
the KM value would require physiologically infeasible
concentration changes.
Recently, reductive glutamine metabolism was suggested
to be initiated by changes in concentrations of substratewww.sciencedirect.com and product of isocitrate dehydrogenase (IDH), specifi-
cally 2-oxoglutarate (2OG) and citrate [5,6,7]. 2OG can
either be oxidatively decarboxylated to succinyl-CoA via
2OG dehydrogenase (OGDH), or it can be reductively
carboxylated via IDH to eventually generate citrate. The
latter metabolic pathway is of particular importance in
different cancer types and under hypoxic conditions for
lipogenesis, when glucose oxidation is suppressed [6,8–
10]. The accumulation of 2OG with a concomitant
decrease in citrate was shown to be the driving force to
switch from oxidative phosphorylation to reductive glu-
tamine metabolism [5,6,7] (Figure 2A). However, a
recent report by Mullen and coworkers showed that
knockdown of OGDH increases the 2OG to citrate ratio,
without inducing reductive glutamine metabolism [11].
The authors concluded that initiation of this metabolic
pathway depends on an increasing NADH/NAD+ ratio.
Therefore, silencing of the NAD+ dependent OGDH
prevented an increase in the NADH/NAD+ ratio and
thus, increased reductive carboxylation of 2OG.Current Opinion in Biotechnology 2015, 34:16–22
18 Systems biology
Figure 2
(d) (e) (f)
(a) 2OG
IDH IDH PKM2 PKM2 ACC ACC
ACC
HIF1αHIF1αHIF1α
P
P
P
AMPKAMPK
ATP
AMP
2OG
MSI1
SCD1
PHD PHD PHD ChREBP
2OG
Citrate AMP
ATP
2OG
Succinate
OH OH
Succinate
Reduction of 2OG Oxidation of 2OG
Desaturation Degradation Degradation
Glycolysis ↑
Lipogenesis
Glucose-6-phosphate
Lipogenesis β-Oxidation
Lipogenesis ↑
Glycolysis ↑ Glycolysis ↓
Serine Biosynthesis ↓ Serine Biosynthesis ↑
cis-ω-9 Fatty Acids O2
M
et
ab
ol
ite
Se
ns
or
M
ed
ia
to
r
Ef
fe
ct
or
M
ed
ia
to
r
Ef
fe
ct
or
M
et
ab
ol
ite
Se
ns
or
Citrate
Fru-1,6-BP
Serine
Fru-1,6-BP
Serine
(b) (c)
Current Opinion in Biotechnology
Regulation of metabolic fluxes by different mechanisms (see text). 2OG: 2-oxoglutarate; Fru-1,6-BP: fructose-1,6-bisphosphate; AMPK: 50 AMP-
activated protein kinase; IDH: isocitrate dehydrogenase; PKM2: pyruvate kinase (M2 isoform); ACC: acetyl-CoA carboxylase; MSI1: musashi1;
PHD: prolyl hydroxylase domain-containing protein; HIF1a: hypoxia inducible factor 1a; SCD1: stearoyl CoA-desaturase-1; ChREBP:
carbohydrate-responsive element-binding protein.Allosteric regulation of enzymes
Although substrate concentrations provide fast and the
most direct means to control enzymatic reactions, they
can affect several metabolic pathways simultaneously
and, thus, cannot specifically increase a flux to produce
a certain metabolite. For instance, high glucose levels will
induce a high glycolytic flux. Since serine is derived from
the glycolytic intermediate glycerate 3-phosphate,
increased glycolysis would increase the flux to serine
biosynthesis, assuming all enzymes are solely regulated
by substrate concentrations. However, the end product of
both pathways is either used for anabolic or catabolic
reactions. Hence, the fluxes through both pathways
should be regulated based on the current metabolic needs
of the cell.
To that end, allosteric regulation of enzyme activity
provide a further means to finely control cellular metab-
olism on a short time scale. Mechanistically, an allostericCurrent Opinion in Biotechnology 2015, 34:16–22 regulator binds an allosteric enzyme at a binding pocket
distinct from the active site, which induces a confor-
mational change modulating the enzyme’s activity. Allo-
steric enzymes show reaction kinetics that deviate from
classical Michaelis–Menten kinetics, changing from
hyperbolic to sigmoidal saturation. As such, the activity
of an allosteric enzyme can either be more sensitive to
concentration changes of its substrate in case of a positive
regulator or its sensitivity can be reduced in the case of a
negative regulator.
Even though allosteric regulation is well known for
around 50 years and many of the pacemaker enzymes
of central carbon metabolism are known to be allos-
terically regulated by metabolites [2], serine was recently
identified as a new allosteric effector of a key glycolytic
enzyme. In addition to fructose-1,6-bisphosphate, serine
was shown to allosterically activate the M2 isoform of
pyruvate kinase (PKM2), which catalyzes the final step ofwww.sciencedirect.com
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with the concomitant generation of ATP [12,13].
Although serine was already identified as a potent acti-
vator of PKM2 in the last century [14], the exact mech-
anism was only elucidated recently. Chaneton and
colleagues identified a previously uncharacterized bind-
ing pocket specific for serine [13]. Based on stable
isotope labeling experiments they showed, that serine
deprivation significantly lowered the flux from phosphoe-
nolpyruvate to pyruvate, leading to an accumulation of
upstream metabolites. The allosteric regulation of PKM2
enables the cell to tightly regulate the bifurcation of
glucose-derived carbon flux into biosynthetic and energy
producing pathways (Figure 2B). If serine levels are low,
PKM2 activity is reduced to shuttle glucose-derived
carbon towards serine biosynthesis. However, if serine
levels are high, PKM2 is fully active, promoting high rates
of glycolysis. This metabolic switch is highly important
for tumor development, as shown by Anastasiou and
coworkers [15]. They showed that expression of
PKM1 or constitutively activated PKM2 inhibits tumor
growth.
Reversible covalent modifications of enzymes
Reversible covalent modifications of specific enzyme
residues provide another means to fine control cellular
metabolism by controlling the enzyme’s activity, subcel-
lular localization, or stability. Post-translational modifi-
cations switch enzymatic activity on or off and therefore
can have a much higher impact than allosteric effectors.
AMP-activated protein kinase (AMPK) is known as key
regulator of metabolism in response to changing ATP/
AMP ratios. If the cellular energy load is low, AMPK is
active and can phosphorylate its targets. Activity of
AMPK itself is regulated by phosphorylation. Whether
ADP or AMP was the actual allosteric regulator to facili-
tate AMPK phosphorylation by upstream kinases was
controversially discussed in the literature [16–18]. Recent
work by Gowans et al. aimed to answer this open question.
Although the cellular concentration of AMP is usually
below that of ADP, the authors showed that AMP is the
true allosteric regulator of AMPK for both, its phosphor-
ylation and its kinase activity [18].
Phosphorylation of AMPK depends on the binding of
AMP or ATP. At high ATP/AMP ratios, ATP binds to the
regulatory domain, resulting in the inactivation of kinase
activity by dephosphorylation of AMPK. If the ATP/AMP
ratio drops, the bound ATP is replaced by AMP. This
leads to a conformational change, favoring phosphoryla-
tion of AMPK by upstream kinases and subsequent
induction of AMPK activity. When the ATP levels rise
again, bound AMP is replaced by ATP resulting in depho-
sphorylation and thus, inactivation of AMPK. When
AMPK is activated it modulates metabolic fluxes: energywww.sciencedirect.com producing processes are induced and energy consuming
processes are repressed [19] (Figure 2C).
A well-known downstream target of AMPK is acetyl-CoA
carboxykinase (ACC) [20]. ACC is the key enzyme in
fatty acid synthesis because it catalyzes malonyl-CoA
production. Malonyl-CoA is the substrate for fatty acid
biosynthesis and acts as an inhibitor of carnitine palmi-
toyltransferase (CPT) which imports fatty acids into the
mitochondrion for b-oxidation. Activated AMPK phos-
phorylates ACC and thereby, prevents inhibition of CPT.
This enables the cell to drive oxidation of lipids into the
mitochondrion to match current energy demands.
Interestingly, AMPK activation reaches beyond regula-
tion of energy metabolism. It has also been shown to
control energy intensive processes such as cell-cycle
progression, protein synthesis or neuronal excitation
[19,21]. In summary, AMPK represents an example of
how metabolite concentrations can be key regulators of
cellular metabolism at the enzyme level by inducing
PTMs.
Translational regulation
Metabolites can also control mRNA translation. Positive
regulation can initiate biosynthesis if precursors are
accumulating and negative regulation is important to
prevent unnecessary production of enzymes if the reac-
tion products are already accumulating.
Negative translational regulation occurs, for example, in
the case of fatty acid desaturation. Unsaturated fatty acids
bind to a translation activator (Musashi-1) and induce a
conformational change. Thereby RNA binding is pre-
vented and mRNA translation of SCD1, a fatty acid
desaturase, is inhibited [22] (Figure 2D).
Besides the indirect regulation of translation via trans-
lation factors, translation can also be controlled by direct
interaction of metabolites with mRNA. Riboswitches are
regulatory domains which can specifically bind certain
metabolites. Binding of the effector induces a confor-
mational change in the mRNA to activate or inactivate
translation. This sensing is well known in bacteria, and
recently a few examples have also been found in eukar-
yotes [23]. Potential riboswitches in mammals remain
elusive. However, it would not be surprising if they were
present there as well, as they provide a direct means for
metabolic control of mRNA translation.
Transcriptional regulation
Complex transcriptional regulation is one of the things
that separates eukaryotes from prokaryotes and provides
the basis for many dedicated cell types within a multi-
cellular organism. Since global changes in gene expres-
sion are energetically expensive, they are usually
triggered by long term environmental changes thatCurrent Opinion in Biotechnology 2015, 34:16–22
20 Systems biologyrequire drastic adaptations of cellular metabolism. For
example, different oxygen levels require distinct sets of
metabolic enzymes, as oxidative phosphorylation is the
most important energy producing pathway under nor-
moxia. The activity of the transcription factor hypoxia
inducible factor 1 (HIF1) is modulated by oxygen
availability. In the presence of oxygen, HIF1a becomes
hydroxylated, which marks the protein for ubiquitina-
tion and proteasomal degradation [24]. In the absence
of oxygen, hydroxylation of the protein is impaired and
proteasomal degradation is avoided. The hydroxylation
is directly controlled by prolyl hydroxylase 2 (PHD2), a
member of the family of dioxygenases. Aside from
oxygen, PHD2 relies on Fe2+ and 2OG to mediate
hydroxylation, with the simultaneous production of
succinate and CO2 from 2OG. In addition to an oxygen
dependent regulation, it has been shown that the
activity of PHD2 as well as other 2OG dependent
dioxygenases can be regulated by the level of succinate
and 2OG, as well as by fumarate and the oncometabo-
lite 2-hydroxyglutarate (2HG) [25,26,27,28,29,30].
When local concentrations of succinate, fumarate, or
2HG increase, protein hydroxylation is inhibited. In the
case of HIF1a, this leads to a stabilization  independent
of the oxygen supply. Stabilized HIF1a forms a com-
plex with HIF1b, and subsequently translocates to the
nucleus, where it binds to HIF response elements
(HRE) and initiates the transcription of target genes.
This leads to metabolic rearrangements such as aerobic
glycolysis (Warburg effect) and reductive carboxylation
of glutamine derived 2OG [5,7,8,9] (Figure 2E).
Interestingly, Sun and Denko recently reported that
HIF1 induces the expression of the ubiquitinating
enzyme SIAH2 which in turn destabilizes a small sub-
unit of OGDH [7], resulting in increased 2OG con-
centrations. In this case, induction of reductive
carboxylation of 2OG by mass action is caused by
transcriptional activation of SIAH2 and subsequent
inhibition of OGDH. The observations made by Sun
and Denko were made in hypoxic cells. Therefore,
HIF1a was stabilized independent of increasing 2OG
concentrations and SIAH2 transcription could be
induced. As described above, reductive carboxylation
of 2OG can also be increased independent of HIF1
solely by changes in the co-factor ratio, as reported by
Mullen and his co-workers [11].
An example of a more direct relationship between a
metabolite and a transcription factor is the carbo-
hydrate-responsive element-binding protein (ChREBP).
ChREBP is known to be affected by different glucose
levels in hepatocytes and acts as a transcription factor by
directly binding to carbohydrate responsive elements
(ChREs) [31]. ChREBP regulates the expression of gly-
colytic and lipogenic enzymes, including pyruvate kinase,
fatty acid synthase, and acetyl-CoA carboxylase [32–34].
To efficiently adjust the activatory effect of ChREBP, aCurrent Opinion in Biotechnology 2015, 34:16–22 mechanism to sense intracellular carbohydrate levels is
required (Figure 2F). Three metabolites have been
reported to modulate ChREBP activity: xylulose-5-phos-
phate, glucose-6-phosphate, and more recently fructose-
2,6-bisphosphate. Due to a predicted binding pocket,
glucose-6-phosphate is the most promising candidate to
directly interact with ChREBP [35].
In addition to changing the localization or binding affinity
of the transcription factors, the accessibility of transcrip-
tion factor binding sites can be altered by chromatin
remodeling. In particular, acetylation of histones has been
implicated in facilitating the binding of transcription
factors and thereby the expression of specific genes. Since
histone acetylation reactions utilize acetyl-CoA as a sub-
strate, it has been speculated that histone acetylations are
regulated as a function of the metabolic state, and more
specifically by intracellular acetyl-CoA levels [36–38].
Most of these speculations are based on a study by Wellen
and colleagues [39] reporting that acetyl-CoA generated
via ATP-citrate lyase (ACL) is necessary for histone
acetylations. Indeed, this study shows that in the absence
of ACL, total histone acetylation levels are reduced and
that nutrient availability changes histone acetylation
levels. However, whether the acetyl-CoA concentration
is the driving force behind the increased histone acety-
lation levels or just a simple correlation remains to be
elucidated. In this context, it would be of interest to
investigate if histone acetyltransferases (HATs) are in
fact sensitive to physiological fluctuations in acetyl-CoA
concentrations.
Conclusion
In this article we discussed how metabolites can regulate
enzymes on various levels, beginning with very direct
mechanisms, such as substrate and product concen-
trations and allosteric modulations to more intricate
and complex transcriptional regulations. Since cellular
metabolism is regulated on many different levels, it is
sometimes not clear whether changing metabolite con-
centrations are cause or consequence of the regulation.
To obtain a more mechanistic understanding of metab-
olite regulation, instead of correlation based assumptions,
the cell’s direct metabolite sensing mechanisms need to
be elucidated. To that end, interdisciplinary approaches
and new experimental methods are required. For
example, compartment-specific metabolite concentration
measurements in combination with computational mod-
eling to detect putative binding pockets in proteins and
nucleic acids will accelerate our understanding of how
metabolites modulate cellular metabolism.
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